The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Mar 30, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how certain changes in a gene called NUDT15 might affect patients with inflammatory bowel disease (IBD) in Taiwan. Researchers want to see if these gene changes are common among IBD patients and how they might influence their health. If you or a family member has been diagnosed with inflammatory bowel disease and is being treated at the National Taiwan University Children's Hospital, you might be eligible to join the study. Participants will need to agree to a simple blood test to check for the NUDT15 gene variant.

If you decide to participate, your blood sample will be tested for the NUDT15 gene, and the results will be compared with your overall health information from your IBD diagnosis. This study is open to individuals aged 1 to 25 years old, regardless of gender. It's important to note that if someone chooses not to have the blood test, they won't be able to participate in this trial. Your involvement could help researchers learn more about the connection between this gene and inflammatory bowel disease, potentially leading to better care for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants who are diagnosed with inflammatory bowel disease.
• Exclusion Criteria:
• • Participants who refused to have blood test for NUDT15 gene evaluation.